SEK147.40
0.27% yesterday
Stockholm, May 20, 05:29 pm CET
ISIN
SE0014428512
Symbol
SUS
Sector

Surgical Science Sweden AB Stock price

SEK147.40
+22.40 17.92% 1M
+5.40 3.80% 6M
-8.50 5.45% YTD
+5.70 4.02% 1Y
-1.70 1.14% 3Y
+88.00 148.15% 5Y
+118.80 415.38% 10Y
Stockholm, Closing price Tue, May 20 2025
+0.40 0.27%
ISIN
SE0014428512
Symbol
SUS
Sector

Key metrics

Market capitalization SEK7.52b
Enterprise Value SEK6.91b
P/E (TTM) P/E ratio 53.31
EV/FCF (TTM) EV/FCF 71.31
EV/Sales (TTM) EV/Sales 7.30
P/S ratio (TTM) P/S ratio 7.95
P/B ratio (TTM) P/B ratio 1.68
Revenue growth (TTM) Revenue growth 12.41%
Revenue (TTM) Revenue SEK946.53m
EBIT (operating result TTM) EBIT SEK174.34m
Free Cash Flow (TTM) Free Cash Flow SEK96.90m
Cash position SEK612.89m
EPS (TTM) EPS SEK2.77
P/E forward 39.35
P/S forward 6.69
EV/Sales forward 6.15
Show more

Is Surgical Science Sweden AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Surgical Science Sweden AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Surgical Science Sweden AB forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Surgical Science Sweden AB forecast:

Buy
80%
Hold
20%

Financial data from Surgical Science Sweden AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
947 947
12% 12%
100%
- Direct Costs 362 362
13% 13%
38%
585 585
12% 12%
62%
- Selling and Administrative Expenses 161 161
18% 18%
17%
- Research and Development Expense 185 185
12% 12%
20%
239 239
8% 8%
25%
- Depreciation and Amortization 64 64
13% 13%
7%
EBIT (Operating Income) EBIT 174 174
6% 6%
18%
Net Profit 141 141
32% 32%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Surgical Science Sweden AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Tom Englund
Employees 274
Founded 1997
Website www.surgical-science.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today